FDA panel votes tomorrow on BPC-157, TB-500, MOTS-c and 4 others - and the FDA's own scientists said no to all of them

so this is happening July 23-24. the PCAC is voting on whether seven of the most-bought peptides get a legal compounding path, and the FDA's own briefing docs already recommended NOT adding a single one. couple things worth knowing that most posts get wrong: the vote is advisory, the FDA decides later through a rulemaking that takes like 6-18 months, and these already came off the "category 2" list in april so a no vote doesn't re-ban anything - it just means gray market stays the only route.

genuinely curious where people think this lands, and more importantly - if a legal pharmacy path did eventually open, would you actually switch to it, or keep sourcing the way you do now?